Related Experiment Video
Updated: Apr 12, 2026

Ovariectomy and 17β-estradiol Replacement in Rats and Mice: A Visual Demonstration
Published on: June 7, 2012
Transdermal estradiol treatment during breastfeeding: maternal and infant serum concentrations
Emily Pinheiro1, Debra L Bogen2, Denada Hoxha3
1Asher Center for the Study and Treatment of Depressive Disorders, Department of Psychiatry and Behavioral Sciences, Northwestern Feinberg School of Medicine, 676. N. St. Clair Street, Suite 1000, Chicago, IL, 60611, USA. emily.pinheiro@northwestern.edu.
We examined estradiol (E2) and estrone (E1) concentrations in breastfeeding mother-infant dyads. The mothers had postpartum depression and were participants in a randomized clinical trial with three treatments (transdermal E2, sertraline, and placebo). Neither infant E1 and E2 concentrations nor infant growth differed across the treatments. Transdermal E2 administration of 50 to 200 mcg/day for breastfeeding women did not affect infant E1 or E2 concentrations or infant growth.
We examined estradiol (E2) and estrone (E1) concentrations in breastfeeding mother-infant dyads. The mothers had postpartum depression and were participants in a randomized clinical trial with three treatments (transdermal E2, sertraline, and placebo). Neither infant E1 and E2 concentrations nor infant growth differed across the treatments. Transdermal E2 administration of 50 to 200 mcg/day for breastfeeding women did not affect infant E1 or E2 concentrations or infant growth.
Related Concept Videos
Intrauterine Drug Delivery Systems
Transdermal Drug Delivery Systems
Drug Dosing: Infants and Children
Pharmacokinetics in Pediatric Patients: Drug Distribution
Transcytosis of IgG
IgG molecules from a mother undergo transcytosis starting around 13 weeks of gestation. The amount of IgG transferred and entering the fetal blood circulation increases with...

